ABVC BioPharma, Inc. (ABVC)
0.9801
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
1.01
+0.03
(+3.05%)
After-Hours: 20:00
ABVC BioPharma Price to Book Value : 2.455 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.455 |
| September 10, 2026 | 2.445 |
| September 09, 2026 | 2.430 |
| September 08, 2026 | 2.655 |
| September 04, 2026 | 2.405 |
| September 03, 2026 | 2.505 |
| September 02, 2026 | 2.165 |
| September 01, 2026 | 2.068 |
| August 31, 2026 | 2.148 |
| August 28, 2026 | 2.079 |
| August 27, 2026 | 1.993 |
| August 26, 2026 | 1.781 |
| August 25, 2026 | 2.004 |
| August 24, 2026 | 2.104 |
| August 21, 2026 | 2.250 |
| August 20, 2026 | 2.250 |
| August 19, 2026 | 2.367 |
| August 18, 2026 | 2.190 |
| August 17, 2026 | 2.149 |
| August 14, 2026 | 2.275 |
| August 13, 2026 | 2.426 |
| August 12, 2026 | 2.427 |
| August 11, 2026 | 2.490 |
| August 10, 2026 | 2.402 |
| August 07, 2026 | 2.579 |
| Date | Value |
|---|---|
| August 06, 2026 | 2.579 |
| August 05, 2026 | 2.554 |
| August 04, 2026 | 2.705 |
| August 03, 2026 | 2.629 |
| July 31, 2026 | 2.554 |
| July 30, 2026 | 2.730 |
| July 29, 2026 | 2.554 |
| July 28, 2026 | 2.680 |
| July 27, 2026 | 2.579 |
| July 24, 2026 | 2.907 |
| July 23, 2026 | 3.034 |
| July 22, 2026 | 2.983 |
| July 21, 2026 | 3.110 |
| July 20, 2026 | 3.034 |
| July 17, 2026 | 3.160 |
| July 16, 2026 | 3.059 |
| July 15, 2026 | 3.236 |
| July 14, 2026 | 3.388 |
| July 13, 2026 | 3.413 |
| July 10, 2026 | 3.818 |
| July 09, 2026 | 3.666 |
| July 08, 2026 | 5.107 |
| July 07, 2026 | 5.107 |
| July 06, 2026 | 4.804 |
| July 02, 2026 | 4.551 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.034 |
| Perspective Therapeutics, Inc. | 0.9899 |
| MiMedx Group, Inc. | 3.083 |
| Abbott Laboratories | 3.452 |
| AngioDynamics, Inc. | 3.728 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0794 |
| Price | 0.9801 |
| Earnings Yield | -29.36% |
| Market Cap | 25.25M |
| PEGY Ratio | -0.0794 |